Search Results - "Del Balzo, Álvaro"
-
1
Differential Immune Checkpoint and Ig-like V-Type Receptor Profiles in COVID-19: Associations with Severity and Treatment
Published in Journal of clinical medicine (08-06-2022)“…Identifying patients' immune system status has become critical to managing SARS-CoV-2 infection and avoiding the appearance of secondary infections during a…”
Get full text
Journal Article -
2
Potential Role of the Galectin-9/TIM-3 Axis in the Disparate Progression of SARS-CoV-2 in a Married Couple: A Case Report
Published in Biomedicine hub (01-01-2021)“…We report the disparate clinical progression of a couple infected by SARS-CoV-2 based on their immune checkpoint (IC) levels and immune cell distribution in…”
Get full text
Journal Article -
3
The immune checkpoints storm in COVID‐19: Role as severity markers at emergency department admission
Published in Clinical and translational medicine (01-10-2021)“…[...]their relevance are still being discussed.1 Patients with severe COVID-19 show an impairment of the immune system allowing secondary infections,2–5 and…”
Get full text
Journal Article -
4
mRNA-1273 boost after BNT162b2 vaccination generates comparable SARS-CoV-2-specific functional responses in naïve and COVID-19-recovered individuals
Published in Frontiers in immunology (21-04-2023)“…COVID-19 vaccines based on mRNA have represented a revolution in the biomedical research field. The initial two-dose vaccination schedule generates potent…”
Get full text
Journal Article -
5
SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19
Published in The Journal of immunology (1950) (01-07-2021)“…According to a large number of reported cohorts, sepsis has been observed in nearly all deceased patients with COVID-19. We and others have described sepsis,…”
Get full text
Journal Article -
6
Proteins from SARS-CoV-2 reduce T cell proliferation: A mirror image of sepsis
Published in Heliyon (01-12-2020)“…Increased cytokine levels, acute phase reactants and immune checkpoint expression changes have been described in patients with Coronavirus Disease 2019…”
Get full text
Journal Article -
7
Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19
Published in Cell reports (Cambridge) (11-01-2022)“…We have analyzed BNT162b2 vaccine-induced immune responses in naive subjects and individuals recovered from coronavirus disease 2019 (COVID-19), both soon…”
Get full text
Journal Article -
8
Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210)
Published in Cytotherapy (Oxford, England) (01-01-2024)“…There are currently no effective anti-viral treatments for coronavirus disease 2019 (COVID-19)-hospitalized patients with hypoxemia. Lymphopenia is a biomarker…”
Get full text
Journal Article -
9
Prior SARS‐CoV‐2 infection balances immune responses triggered by four EMA‐approved COVID‐19 vaccines: An observational study
Published in Clinical and translational medicine (01-05-2022)“…Other authors have reported that in natural infection anti-Spike RBD IgA antibodies showed to be the major responsible of the neutralizing ability in early…”
Get full text
Journal Article